According to a recent EXPRESS article, pharmaceutical giant Pfizer is looking to maximize its mRNA technology for a second vaccine. The same messenger ribonucleic concept that propelled their COVID-19 vaccine at warp speed is now being applied to a vaccine for influenza. The company announced it will begin testing the vaccine in a Phase 1 clinical trial to test safety and efficacy.
Pfizer’s mRNA Flu Vaccine is Coming
The influenza vaccine was designed with the same mRNA technology as Pfizer’s COVID-19 shot.
Oct 4, 2021
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
